0001209191-18-035717.txt : 20180605
0001209191-18-035717.hdr.sgml : 20180605
20180605163850
ACCESSION NUMBER: 0001209191-18-035717
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180601
FILED AS OF DATE: 20180605
DATE AS OF CHANGE: 20180605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ULLIAN ELAINE
CENTRAL INDEX KEY: 0001190290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18881647
MAIL ADDRESS:
STREET 1: C/O HOLOGIC, INC.
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001190290
ULLIAN ELAINE
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2018-06-01
4
A
0
1801
0.00
A
12195
D
Stock Option (Right to Buy)
152.74
2018-06-01
4
A
0
3229
0.00
A
2028-05-31
Common Stock
3229
3229
D
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
Fully vested.
/s/ Stephen Migausky, Attorney-in-Fact
2018-06-05